Skip to content
Loading…
Bloomberg's Poonam Goyal said Walmart's earnings miss is largely due to lagging pharmaceutical sales impacted by new federal negotiations aimed at delivering lower drug prices. Goyal said that it's an issue that both the company and investors are expecting to continue affecting…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.